SonoScape Medical Corp.

Shenzhen Stock Exchange 300633.SZ

SonoScape Medical Corp. Return on Equity (ROE) for the year ending December 31, 2023: 14.45%

SonoScape Medical Corp. Return on Equity (ROE) is 14.45% for the year ending December 31, 2023, a 7.02% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

SonoScape Medical Corp. Return on Equity (ROE) for the year ending December 31, 2022 was 13.50%, a 28.57% change year over year.
SonoScape Medical Corp. Return on Equity (ROE) for the year ending December 31, 2021 was 10.50%, a 405.20% change year over year.
SonoScape Medical Corp. Return on Equity (ROE) for the year ending December 31, 2020 was -3.44%, a -147.57% change year over year.
SonoScape Medical Corp. Return on Equity (ROE) for the year ending December 31, 2019 was 7.23%, a -62.48% change year over year.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

Shenzhen Stock Exchange: 300633.SZ

SonoScape Medical Corp.

CEO	Mr. Kunxiang Wu
IPO Date	April 7, 2017
Location	China
Headquarters	Shenzhen Software Park, 12
Employees	2,697
Sector	Healthcare
Industries Medical Instruments 3D Printing Biotechnology Defense & Military Hardware & Electronics Plastics Robotics

Description

SonoScape Medical Corp. develops and manufactures medical equipment in China and internationally. The company offers ultrasound diagnostic systems, such as trolley color Doppler, portable color Doppler, B/W ultrasound, and veterinary ultrasound equipment; and endoscopy equipment, such as image processors, light sources, and gastroenterology products. It also provides technical and spare parts support, training, upgradation, and field services. SonoScape Medical Corp. was founded in 2002 and is based in Shenzhen, China.

Key trends

Past 5 years